Seborrheic Dermatitis on the Face Completed Phase 2 Trials for Azelaic acid (DB00548)

IndicationStatusPhase
DBCOND0036556 (Seborrheic Dermatitis on the Face)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00408330A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the FaceTreatment